Aurora Cannabis Inc. (ACB) - What Are Investment Firms Saying About This Stock?

Key Points

• Analysts broadly lean negative: Aurora Cannabis has a consensus “Reduce” rating from five analysts—two sell, two hold and one buy. Recent rating changes were mixed, including TD Securities’ downgrade to “strong sell.”
• Aurora reported quarterly EPS of $0.04, beating the consensus estimate of a $0.13 loss, while revenue of $47.62 million narrowly exceeded forecasts. The company still posted a negative net margin of 32.26%.
• Institutional investors and hedge funds own 47.63% of Aurora’s shares, and several reported increasing or initiating positions. Shares opened at $5.24, within a 12-month range of $2.56 to $6.36.

Shares of Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) have been assigned a consensus rating of "Reduce" from the five analysts that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating on the company.

Several brokerages recently issued reports on ACB. Zacks Research lowered Aurora Cannabis from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 5th. Wall Street Zen upgraded Aurora Cannabis from a "sell" rating to a "hold" rating in a research note on Sunday, September 13th. Weiss Ratings raised Aurora Cannabis from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, October 2nd. BMO Capital Markets upgraded Aurora Cannabis to a "hold" rating in a research note on Wednesday, August 5th. Finally, TD Securities lowered shares of Aurora Cannabis from a "strong-buy" rating to a "strong sell" rating in a report on Tuesday.

Institutional Investors Weigh In On Aurora Cannabis

A number of institutional investors and hedge funds have recently made changes to their positions in ACB. Two Sigma Securities LLC bought a new position in shares of Aurora Cannabis in the second quarter valued at approximately $36,000. State of Wyoming bought a new stake in shares of Aurora Cannabis during the 2nd quarter valued at $56,000. Baader Bank Aktiengesellschaft lifted its stake in Aurora Cannabis by 37.3% in the 1st quarter. Baader Bank Aktiengesellschaft now owns 33,060 shares of the company's stock worth $108,000 after purchasing an additional 8,990 shares in the last quarter. Finally, Tidal Investments LLC raised its stake in Aurora Cannabis by 1.2% in the second quarter. Tidal Investments LLC now owns 1,264,494 shares of the company's stock valued at $3,528,000 after purchasing an additional 14,827 shares in the last quarter. Institutional investors and hedge funds own 47.63% of the company's stock.

Aurora Cannabis Stock Performance

Shares of NASDAQ:ACB opened at $5.24 on Thursday. Aurora Cannabis has a twelve month low of $2.56 and a twelve month high of $6.36. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.80 and a current ratio of 5.36. The business has a fifty day moving average of $4.10 and a 200-day moving average of $3.56. The firm has a market cap of $344.39 million, a PE ratio of -3.72 and a beta of 0.65.

Aurora Cannabis (NASDAQ:ACB - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.17. The business had revenue of $47.62 million for the quarter, compared to analyst estimates of $47.45 million. Aurora Cannabis had a negative net margin of 32.26% and a positive return on equity of 4.37%. On average, equities research analysts predict that Aurora Cannabis will post -0.07 EPS for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces, distributes and sells cannabis and cannabis-derived products for medical and adult-use markets. Its shares trade on the Toronto Stock Exchange and the Nasdaq under the symbol ACB.

Aurora's product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes and other cannabis extracts. The company markets products through brands such as Aurora, San Rafael '71, Daily Special and CanniMed, with offerings varying by market and applicable regulations.

The company serves Canada's regulated adult-use and medical cannabis markets and has expanded its medical cannabis business internationally.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.